Vital funding for Maxion autoimmune disease research
Effective treatment of AID is still a considerable area of unmet medical requirements - News - PharmaTimes
Source: pharmatimes.com
Page 3 - Biomedical Catalyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biomedical Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biomedical Catalyst Today - Breaking & Trending Today
NOFO: Investor Partnership Programme in the UK
Deadline: 29-Mar-23 Investors can apply to partner with Innovate UK to invest in innovative SMEs aligned with grant funding. Innovate UK will support
Source: fundsforngos.org
Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment
Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris.
Source: news-medical.net
Alchemab, MDC receive grant to develop Huntington's disease therapy
Alchemab Therapeutics and MDC have received $2.06m grant from Innovate UK to accelerate the development of disease modifying therapy
Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington's Disease
/PRNewswire/ -- Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today announced that it has been awarded...
Source: prnewswire.com